Insight Into Subcutaneous Adipose Tissue Disorders
NCT02838277 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2017-09-15
Summary
The INSIGHT study aims to phenotype individuals with subcutaneous adipose tissue (SAT) disorders specifically lipedema and Dercum's disease with an aim to find a cure for the SAT in these disorders that is resistant to diet and exercise.
Conditions
- Lipedema
- Dercum's Disease
- Familial Multiple Lipomatosis
- Madelung's Disease
Sponsors & Collaborators
-
Lipedema Foundation
collaborator OTHER -
University of Arizona
lead OTHER
Principal Investigators
-
Karen L Herbst, PhD, MD · University of Arizona
Eligibility
- Min Age
- 19 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2018-06-30
- Completion
- 2018-12-31
Countries
- United States
Study Locations
More Related Trials
-
Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices
NCT07268937 ·Status: COMPLETED
-
Identification of Liver Fibrosis Biomarkers
NCT06819917 ·Status: RECRUITING
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy
NCT01100398 ·Status: COMPLETED
-
Mitochondrial Metabolism and Hepatic Complications of Obesity
NCT03302481 ·Status: WITHDRAWN ·Phase: NA
-
Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD
NCT06147947 ·Status: RECRUITING
-
Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD
NCT06147934 ·Status: RECRUITING
-
Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171)
NCT01110577 ·Status: COMPLETED
-
Accurate Point of Care Liver Disease Diagnostics
NCT05986916 ·Status: ACTIVE_NOT_RECRUITING
-
Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome
NCT00399932 ·Status: UNKNOWN
-
Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD
NCT04681573 ·Status: RECRUITING ·Phase: NA
-
Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
NCT00584402 ·Status: COMPLETED ·Phase: NA
-
RISK FACTORS OF GALL BLADDER STONE
NCT04822519 ·Status: COMPLETED
-
Biomarkers of Steatohepatitis in Type 2 Diabetes Patients
NCT07098520 ·Status: NOT_YET_RECRUITING
-
Diagnosis of Fatty Liver With Outpatient Ultrasound
NCT03542578 ·Status: RECRUITING
-
Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease
NCT02779946 ·Status: COMPLETED
-
Outcome and Related Factors of Necrotizing Fasciitis of the Limb
NCT00538577 ·Status: COMPLETED
-
Biomarkers in the Diagnosis and Prognosis of NAFLD
NCT06098417 ·Status: RECRUITING
-
Fatty Liver Imaging Project
NCT03757832 ·Status: COMPLETED
-
Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation
NCT02859753 ·Status: COMPLETED ·Phase: NA
-
Robotic-assisted Percutaneous Transhepatic Puncture
NCT06195917 ·Status: RECRUITING ·Phase: NA
-
Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography
NCT01360892 ·Status: UNKNOWN
-
Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis
NCT06160271 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients
NCT02793791 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis
NCT02456766 ·Status: UNKNOWN